相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The remarkable characteristics of the children with colchicine-resistant familial Mediterranean fever in Turkey
Nihal Sahin et al.
MODERN RHEUMATOLOGY (2022)
Twenty-Year Experience of a Single Referral Center on Pediatric Familial Mediterranean Fever What Has Changed Over the Last Decade?
Rabia Miray Kisla Ekinci et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2021)
The assessment of tocilizumab therapy on recurrent attacks of patients with familial Mediterranean fever: A retrospective study of 15 patients
Seda Colak et al.
MODERN RHEUMATOLOGY (2021)
Fast diagnostic test for familial Mediterranean fever based on a kinase inhibitor
Flora Magnotti et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Do all colchicine preparations have the same effectiveness in patients with familial Mediterranean fever?
Esra Baglan et al.
MODERN RHEUMATOLOGY (2021)
Defining colchicine resistance/intolerance in patients with familial Mediterranean fever: a modified-Delphi consensus approach
Seza Ozen et al.
RHEUMATOLOGY (2021)
COVID-19 in patients with familial Mediterranean fever treated with colchicine: case based review
Kemal Nas et al.
RHEUMATOLOGY INTERNATIONAL (2021)
IL-1 Inhibitors in the Treatment of Monogenic Periodic Fever Syndromes: From the Past to the Future Perspectives
Hana Malcova et al.
FRONTIERS IN IMMUNOLOGY (2021)
Incidence and course of COVID-19 hospitalizations among patients with familial Mediterranean fever
Fadi Kharouf et al.
RHEUMATOLOGY (2021)
The impact of COVID-19 on familial Mediterranean fever: a nationwide study
Zafer Gunendi et al.
RHEUMATOLOGY INTERNATIONAL (2021)
Next Generation Sequencing Based Multiplex Long-Range PCR for Routine Genotyping of Autoinflammatory Disorders
Ferhat Guzel et al.
FRONTIERS IN IMMUNOLOGY (2021)
Evaluation of E148Q and Concomitant AA Amyloidosis in Patients with Familial Mediterranean Fever
Zehra Serap Arici et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Safety and efficacy of intravenous Colchicine in children with Familial Mediterranean Fever
Rotem Tal et al.
RHEUMATOLOGY INTERNATIONAL (2020)
Successful management of colchicine resistant familial Mediterranean fever patients with a standardized canakinumab treatment protocol: a case series and literature review
Sanem Eren Akarcan et al.
RHEUMATOLOGY INTERNATIONAL (2020)
Long-term effectiveness and safety of canakinumab in pediatric familial Mediterranean fever patients
Nesrin Gulez et al.
MODERN RHEUMATOLOGY (2020)
An open-label continuation trial of tocilizumab for familial Mediterranean fever with colchicine ineffective or intolerance Study protocol for investigator-initiated, multicenter, open-label trial
Tomohiro Koga et al.
MEDICINE (2020)
Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review
Hazan Karadeniz et al.
RHEUMATOLOGY INTERNATIONAL (2020)
Blood-based test for diagnosis and functional subtyping of familial Mediterranean fever
Hanne Van Gorp et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease
Emanuele Pontali et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Anti-IL1 treatment in colchicine-resistant paediatric FMF patients: real life data from the HELIOS registry
Erdal Sag et al.
RHEUMATOLOGY (2020)
Colchicine and Leukopenia: Clinical Implications
Erdal Sag et al.
JOURNAL OF PEDIATRICS (2020)
Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial
Seza Ozen et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Effect of anti-interleukin-1 treatment on quality of life in children with colchicine-resistant familial Mediterranean fever: A single-center experience
Tuba Kurt et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2020)
A systematic literature review of efficacy, effectiveness and safety of biologic therapies for treatment of familial Mediterranean fever
Jasmin B. Kuemmerle-Deschner et al.
RHEUMATOLOGY (2020)
Analysis of polymorphisms in the colchicine binding site of tubulin in colchicine-resistant familial Mediterranean fever patients
Tayfun Hilmi Akbaba et al.
MOLECULAR BIOLOGY REPORTS (2020)
Canakinumab in colchicine resistant familial Mediterranean fever and other pediatric rheumatic diseases
Mustafa Cakan et al.
TURKISH JOURNAL OF PEDIATRICS (2020)
Sacroiliitis associated with familial Mediterranean fever in childhood: a case series and review of literature
Deniz Gezgin Yildirim et al.
TURKISH JOURNAL OF PEDIATRICS (2020)
Sacroiliitis in Children With Familial Mediterranean Fever
Fatma Aydin et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2019)
Familial Mediterranean Fever
Huri Ozdogan et al.
PRESSE MEDICALE (2019)
Classification criteria for autoinflammatory recurrent fevers
Marco Gattorno et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Short-term follow-up results of children with familial Mediterranean fever after cessation of colchicine: is it possible to quit?
Ayse Tanatar et al.
RHEUMATOLOGY (2019)
Age dependent safety and efficacy of colchicine treatment for familial mediterranean fever in children
Oh Goldberg et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)
Canakinumab in Children with Familial Mediterranean Fever: A Single-Center, Retrospective Analysis
Rabia Miray Kisla Ekinci et al.
PEDIATRIC DRUGS (2019)
The Pyrin Inflammasome in Health and Disease
Oskar Schnappauf et al.
FRONTIERS IN IMMUNOLOGY (2019)
Familial Mediterranean fever: breaking all the (genetic) rules
Alessandro Stella et al.
RHEUMATOLOGY (2019)
Efficacy and safety of long-term treatment with intravenous colchicine for familial Mediterranean fever (FMF) refractory to oral colchicine
Chagai Grossman et al.
RHEUMATOLOGY INTERNATIONAL (2019)
Protracted febrile myalgia as a challenging manifestation of familial Mediterranean fever: case-based review
Deniz Gezgin Yildirim et al.
RHEUMATOLOGY INTERNATIONAL (2019)
Familial Mediterranean fever in childhood: a single-center experience
Kenan Barut et al.
RHEUMATOLOGY INTERNATIONAL (2018)
Biologics for the Treatment of Juvenile Idiopathic Arthritis
Dimitri Poddighe et al.
CURRENT MEDICINAL CHEMISTRY (2018)
Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes
F. De Benedetti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Canakinumab treatment in children with familial Mediterranean fever: report from a single center
Fatma Yazilitas et al.
RHEUMATOLOGY INTERNATIONAL (2018)
Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial
Tomohiro Koga et al.
TRIALS (2018)
Discontinuing colchicine in symptomatic carriers for MEFV (Mediterranean FeVer) variants
Hafize Emine Sonmez et al.
CLINICAL RHEUMATOLOGY (2017)
Canakinumab for the treatment of familial Mediterranean fever
Huri Ozdogan et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2017)
Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever
Serdal Ugurlu et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Familial Mediterranean fever in children and adolescents: factors for colchicine dosage and predicting parameters for dose increase
Anne-Marie Knieper et al.
RHEUMATOLOGY (2017)
Anakinra for Colchicine-Resistant Familial Mediterranean Fever A Randomized, Double-Blind, Placebo-Controlled Trial
Ilan Ben-Zvi et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases
Gabriele Fenini et al.
FRONTIERS IN PHARMACOLOGY (2017)
Familial Mediterranean fever, review of the literature
Mansour Alghamdi
CLINICAL RHEUMATOLOGY (2017)
The novel interleukin-1 cytokine family members in inflammatory diseases
Madelaine Hahn et al.
CURRENT OPINION IN RHEUMATOLOGY (2017)
The effect of colchicine and disease severity on physical growth in children with familial Mediterranean fever
Tuba Celen Yoldas et al.
CLINICAL RHEUMATOLOGY (2016)
Performance of Different Diagnostic Criteria for Familial Mediterranean Fever in Children with Periodic Fevers: Results from a Multicenter International Registry
Erkan Demirkaya et al.
JOURNAL OF RHEUMATOLOGY (2016)
Successful treatment with humanized anti-interleukin-6 receptor antibody (tocilizumab) in a case of AA amyloidosis complicated by familial Mediterranean fever
Satoshi Hamanoue et al.
MODERN RHEUMATOLOGY (2016)
Efficacy and safety of treatments in Familial Mediterranean fever: a systematic review
Erkan Demirkaya et al.
RHEUMATOLOGY INTERNATIONAL (2016)
EFFICACY OF BIOLOGICAL AGENTS IN COLCHICINE RESISTANT CHILDREN WITH FMF
N. Aktay Ayaz et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
EULAR recommendations for the management of familial Mediterranean fever
Seza Ozen et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Late-onset disease is associated with a mild phenotype in children with familial Mediterranean fever
Semanur Ozdel et al.
CLINICAL RHEUMATOLOGY (2016)
Familial Mediterranean fever
Shai Padeh et al.
CURRENT OPINION IN RHEUMATOLOGY (2016)
Comparison of the efficacy of once- and twice-daily colchicine dosage in pediatric patients with familial Mediterranean fever - a randomized controlled noninferiority trial
Adem Polat et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever
Gabriella Giancane et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Colchicine, Biologic Agents and More for the Treatment of Familial Mediterranean Fever. The Old, the New, and the Rare
P. Portincasa
CURRENT MEDICINAL CHEMISTRY (2015)
Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents
Fehime Kara Eroglu et al.
RHEUMATOLOGY INTERNATIONAL (2015)
Rilonacept Pharmacokinetics in Children With Systemic Juvenile Idiopathic Arthritis
Julie Autmizguine et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Interleukin-1 targeting treatment in familial Mediterranean fever: an experience of pediatric patients
Ozge Basaran et al.
MODERN RHEUMATOLOGY (2015)
Reviewing Colchicaceae Alkaloids - Perspectives of Evolution on Medicinal Chemistry
Sonny Larsson et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2014)
The Effect of Rilonacept versus Placebo on Health-Related Quality of Life in Patients with Poorly Controlled Familial Mediterranean Fever
Philip J. Hashkes et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Canakinumab for the treatment of children with colchicine-resistant familial Mediterranean fever: a 6-month open-label, single-arm pilot study
Riva Brik et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Efficacy and Safety of Biologic Treatments in Familial Mediterranean Fever
Ozgur Akgul et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2013)
Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review
Nienke ter Haar et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Colchicine Treatment in Children With Familial Mediterranean Fever: Is it a Risk Factor for Neuromyopathy?
Sedat Isikay et al.
PEDIATRIC NEUROLOGY (2013)
Treating inflammation by blocking interleukin-1 in humans
Charles A. Dinarello et al.
SEMINARS IN IMMUNOLOGY (2013)
Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes
Saik Urien et al.
BMC PHARMACOLOGY & TOXICOLOGY (2013)
Rilonacept for Colchicine-Resistant or -Intolerant Familial Mediterranean Fever A Randomized Trial
Philip J. Hashkes et al.
ANNALS OF INTERNAL MEDICINE (2012)
A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features
Nicolino Ruperto et al.
ARTHRITIS AND RHEUMATISM (2012)
Incomplete response to colchicine in M694V homozygote FMF patients
Merav Lidar et al.
AUTOIMMUNITY REVIEWS (2012)
PHARMACOKINETICS OF COLCHICINE IN PEDIATRIC AND ADULT PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER
Y. Berkun et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2012)
Colchicine is a Safe Drug in Children with Familial Mediterranean Fever
Shai Padeh et al.
JOURNAL OF PEDIATRICS (2012)
The Impact of Familial Mediterranean Fever on Women's Health
Sarah Dotters-Katz et al.
OBSTETRICAL & GYNECOLOGICAL SURVEY (2012)
An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site
Yan Lu et al.
PHARMACEUTICAL RESEARCH (2012)
Anti-Interleukin 1 Treatment for Patients with Familial Mediterranean Fever Resistant to Colchicine
Seza Ozen et al.
JOURNAL OF RHEUMATOLOGY (2011)
Association between ABCB1 (MDR1) Gene 3435 C > T Polymorphism and Colchicine Unresponsiveness of FMF Patients
Filiz Ozen et al.
RENAL FAILURE (2011)
Colchicine poisoning: the dark side of an ancient drug
Yaron Finkelstein et al.
CLINICAL TOXICOLOGY (2010)
The effect of colchicine on physical growth in children wA±th familial mediterranean fever
Z. Birsin Oezcakar et al.
EUROPEAN JOURNAL OF PEDIATRICS (2010)
Photochemical Transformation of Colchicine: A Kinetic Study
Raed Ghanem et al.
JOURNAL OF SOLUTION CHEMISTRY (2010)
Immunological and Inflammatory Functions of the Interleukin-1 Family
Charles A. Dinarello
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy
Jae J. Chae et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Sulphasalazine treatment in protracted familial Mediterranean fever arthritis
Sevcan A. Bakkaloglu et al.
EUROPEAN JOURNAL OF PEDIATRICS (2009)
Colchicine Update: 2008
Robert A. Terkeltaub
SEMINARS IN ARTHRITIS AND RHEUMATISM (2009)
Early suppression of familial Mediterranean fever attacks by single medium dose methyl-prednisolone infusion
Eren Erken et al.
JOINT BONE SPINE (2008)
Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin
Bhabatarak Bhattacharyya et al.
MEDICINAL RESEARCH REVIEWS (2008)
Colchicine use in children and adolescents with familial Mediterranean fever: Literature review and consensus statement
Tilmann Kallinich et al.
PEDIATRICS (2007)
The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1β production
Jae Jin Chae et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The B-ring substituent at C-7 of colchicine and the α-C-terminus of tubulin communicate through the tail-body interaction
S Chakraborty et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2004)
分享论文
